TSLP inhibitor Tezspire clinically has validated Thymic Stromal LymphoPoietin (TSLP) as a valid target for treatment of inflammatory diseases by its approval in late 2021 in the US and in 2022 in ...

A study published in July 2025 issue of Journal of Allergy and Clinical Immunology Global highlighted persistent challenges and fragmented care in managing individuals with severe asthma with an ...

Primary care physicians play a vital role in identifying red flags for rare eosinophilic diseases like HES and EGPA, enabling ...

The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the ...

The last search was conducted in February 2017. All randomised controlled comparisons of adjustment of asthma therapy based on sputum eosinophils compared to traditional methods (primarily clinical ...

Background Previous studies in adults with asthma incorporating the control of sputum eosinophils into management strategies have shown significant reductions in exacerbations. A study was undertaken ...

Pressurised metered dose inhalers versus all other hand-held inhaler devices to deliver beta-2 agonist bronchodilators for non-acute asthma ...

Allegheny Health Network has opened a new clinic to provide cpecialty care for patients with complex asthma, allergies and related diseases.

Background and aims: Current assessments for diagnosing and monitoring eosinophilic esophagitis (EoE) are invasive, time-intensive and costly. The development of non-invasive biomarkers that are ...

Patients with eosinophilic esophagitis in the US have high health care resource utilization costs, according to a retrospective national claims study.